SEC Comment Letter 0000000000-24-009391 to Jushi Holdings Inc. (JUSHF) (CIK 0001909747) (JUSHF)
Jushi Holdings Inc. (JUSHF) (CIK 0001909747)
Date: Aug. 15, 2024 · CIK: 0001909747 · Accession: 0000000000-24-009391
AI Filing Summary & Sentiment
File numbers found in text: 000-56468
Show Raw Text
August 15, 2024
Michelle Mosier
Chief Financial Officer
Jushi Holdings Inc.
301 Yamato Road, Suite 3250
Boca Raton, FL 33431
Re:Jushi Holdings Inc.
Form 10-K for the Year Ended December 31, 2023
Filed April 1, 2024
File No. 000-56468
Dear Michelle Mosier:
We have limited our review of your filing to the financial statements and related
disclosures and have the following comment.
Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe
the comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments.
Form 10-K for the Year Ended December 31, 2023
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations, page 62
We note your response to prior comment one as well as the related disclosures in your
Form 10-Q for the period ended June 30, 2024. We continue to believe the absence of
sufficient quantification to allow the reader to gauge the respective impact of the factors
you cite for the changes in each of your retail and wholesale revenue results in disclosure
that lacks sufficient transparency. For example, while the disclosure on page 28 of your
Form 10-Q appears to quantify the impact of rate versus volume on the retail revenue
from certain states, without quantifying the revenue reported for each state for the periods
addressed, the reader is left without the ability to gauge the respective significance of each
state to your total retail revenue. Similarly, your disclosure addressing your wholesale
revenue does not give the reader the ability to gauge the respective impact of the
individual state factors you cited in your disclosure. Please provide us with proposed
revisions to your Form 10-Q for the period ended June 30, 2024 with a view to providing 1.
August 15, 2024
Page 2
improved disclosure in your Form 10-Q for the period ended September 30, 2024.
In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Jenn Do at 202-551-3743 or Kevin Vaughn at 202-551-3494 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences